5.030USD-2.14%Mkt Cap: 273.68M USDP/E: —Last update: 2026-05-22
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The …
Industry Peers
Medical Devices152.25BUSDP/E 24.5
85.88BUSDP/E 24.2
53.45BSEKP/E 22.7
53.33BSEKP/E 98.9
52.13BDKKP/E 22.1
38.61BEURP/E 18.3
23.15BSEK—
22.25BEURP/E 23.4
loading…
Indicators:|
Key Statistics
Company
Market Cap273.68M USD
Enterprise Value236.47M USD
Revenue (TTM)79.55M USD
Gross Profit66.67M USD
Net Income (TTM)-38.43M USD
Revenue/Share1.506 USD
Last Price5.030 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees186
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-7.79
PEG—
EV/EBITDA-8.75
EV/Revenue2.97
P/S3.52
P/B4.30
EPS (TTM)-0.70
EPS (Forward)-0.66
52W Range
3.11031% of range9.236
52W High9.236 USD
52W Low3.110 USD
Profitability
Gross Margin86.17%
Oper. Margin-35.60%
EBITDA Margin-33.96%
Profit Margin-49.67%
ROE-60.10%
ROA-33.33%
Growth
Revenue Growth12.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-29.69M USD
CapEx (TTM)224.00K USD
FCF Margin-10.78%
FCF Yield-3.13%
Net Debt-43.20M USD
Net Debt/EBITDA1.60
Balance Sheet
Debt/Equity0.64
Current Ratio5.86
Quick Ratio5.26
Book Value/Sh1.195 USD
Cash/Share1.562 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Target (Mean)8.338 USD
Target Range4.350 USD – 12.00 USD
# Analysts4
Ownership
Shares Out.54.41M
Float35.39M
Insiders20.01%
Institutions53.95%
Short Interest
Short Ratio2.7d
Short % Float2.37%
Short % Out.1.72%
Shares Short936.89K
Short (prev mo.)1.07M
Technical
SMA 504.153 (+21.1%)
SMA 2005.211 (-3.5%)
Beta2.38
S&P 52W Chg28.31%
Avg Vol (30d)303.14K
Avg Vol (10d)233.01K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—